Trial Search Results

On-Line Intervention to Lower Cardiovascular Risk in Pediatric Heart Transplant Patients

Pediatric heart transplant patients have a high-risk cardiovascular profile affecting their long-term outcomes and survival. Currently, no effective cardiovascular preventative care is provided for this pediatric population, in part, due to the fact that clinic-based programs are not easily accessible to children and their families. However, tele-health has been show to improve medical outcomes by making care more accessible to these patients. This study aims to meet the urgent need for an effective and sustainable delivery of preventative care to pediatric heart transplant patients using a diet and exercise intervention program delivered live over the internet direct to these patients' homes.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Other: On-Line Diet and Exercise Intervention

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Heart transplant >11 months before baseline visit

   - Able to fast overnight

   - Cardiac clearance to exercise by the primary cardiologist

   - Presence of an adult at home during the exercise training sessions for patients < 14
   years of age

Exclusion Criteria:

   - Acute illness

   - Latex allergy

   - Document transplant rejection < 3 months

   - Re-transplantation or multi-organ transplantation

   - Malignancy

Ages Eligible for Study

9 Years - 19 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting